A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
TRADING UPDATES: Beximco s India jab mire; Lamprell gets Aramco deal
Wed, 28th Apr 2021 14:04
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Beximco Pharmaceuticals Ltd - Bangladesh-based generic pharmaceutical products and active pharmaceutical ingredients maker - Says agreement with Bangladeshi government and Serum Institute of India Pvt Ltd to deliver 30 million vaccine doses to Bangladesh is hit by India jabs export ban. Does not expect SII to be able to deliver remaining 23 million doses by end of June as India places ban on vaccine exports as cases there surge. The company will collaborate with SII to provide a revised supply schedule once the temporary export controls are relaxed. The expected positive impact on the current financial year, as outlined in the announcement on 5 November 2020, may therefore be mitigated, Beximco says. In addition, Beximco Pharma confirms